A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center

List of posts


  • Stephan Moll, MD writes (last updated: Sept 9th, 2020)… Background:  Hospitalized patients with COVID-19 are at increased risk for thrombosis – DVT, PE, and may be pulmonary micro-vascular thrombosis that possibly contributes to respiratory failure; arterial events appear to occur less commonly. Scientific/clinical data on prevalence of thrombosis, best prevention, and optimal therapy are limited.…

    Read more

  • Emily Hawes, UNC School of Pharmacy, writes…  Patients on blood thinners are at increased risk for bleeding.  This can be easy to recognize external bleeding (bruising, bleeding from a cut, nosebleeds, etc.) or more occult internal bleeding.  Patients need to know how to recognize abnormal bleeding.  If any of the below signs of abnormal bleeding occur patients need…

    Read more

  • At times, patients on anticoagulants are considering getting a tattoo.  I am not aware of any medical publication assessing the amount of bleeding with tattooing on warfarin or other anticoagulants.

    Read more

  • At times, individuals who are on blood thinners are considering getting a tattoo.  I am not aware of any medical publication assessing the amount of bleeding that were to occur if a patient got a tattoo while on warfarin or other blood thinners.

    Read more

  • Liz Varga, Certified Genetic Counselor, Nationwide Children’s Hospital, Columbus OH writes…. Some patients or their family members may be concerned about genetic testing for thrombophilias for fear of genetic discrimination.  Fortunately in the United States, laws are in place that can alleviate this concern. 

    Read more

  • Liz Varga, Certified Genetic Counselor, Nationwide Children’s Hospital, Columbus OH writes…. Some people may have concerns about genetic testing for clotting disorders (thrombophilias) for fear of genetic discrimination.  Fortunately in the United States, we have laws in place that can alleviate this concern.

    Read more

  • Beth Waldron, Program Director of the Clot Connect project, writes…. Approximately 1 in 5 people don’t take a medication a doctor has prescribed because they can’t afford to pay for it [ref 1].  While the cost of some outpatient “blood thinning” therapies (anticoagulants) can be substantial, failure to take a blood thinning medication as prescribed…

    Read more

  • Beth Waldron, Program Director of the Clot Connect project, writes…. While the cost of some outpatient anticoagulation therapies can be substantial, failure to take an anticoagulant medication as prescribed can have serious, even deadly, consequences.   Links to resources which may help patients when they are prescribed an anticoagulant that they cannot afford is available in this article.…

    Read more

  • A major North American thrombosis & hemostasis  conference will take place May 3-5, 2012, in Chicago at the Hyatt Regency.  This meeting is mostly geered towards health care professionals of various specialties  interested in and taking care of patients with thrombotic and bleeding disorders.  It will provide state-of -the-art clinical management updates and relevant research developments, as well…

    Read more

  • A major North American thrombosis & hemostasis  conference will take place May 3-5, 2012, in Chicago at the Hyatt Regency.  This meeting is mostly geered towards health care professionals of various specilaties  interested in and taking care of patients with thrombotic and bleeding disorders.  However, there is also a small patient education track – the content is still being…

    Read more

  • While many people who have a DVT in a leg or arm recover completely, others can be left with some chronic symptoms: leg or arm swelling, pain, aching, heaviness, and cramping are some of the symptoms. These symptoms, in the case of a leg DVT, are typically worse after standing for a long time, and may…

    Read more